Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Psychiatry
•
Community Psychiatry
•
General Psychiatry
Is there a benefit to augmenting treatment for schizophrenia by adding aripiprazole (a partial D2 agonist) to a full D2 antagonist such as haloperidol?
Related Questions
How do you approach treatment-refractory schizophrenia which has not responded to multiple antipsychotic trials including clozapine?
How do you manage nausea side effects in patients on cariprazine?
How do you approach the use of SSRIs to treat bipolar depression?
When do you use seizure prophylaxis in patients on clozapine?
When do you choose to switch to antidepressants vs augmentation in treatment-resistant depression?
What are the most effective strategies for managing weight gain associated with antipsychotic medications?
When do you consider using multiple antipsychotic medications for chronic management of psychosis?
How do you approach a treatment relationship with a patient who is non-adherent to recommendations and also is not interested in transfer to another practitioner?
What is your approach for managing persistent psychotic symptoms hallucinogenic-induced persisting psychotic disorder (for example related to SUD involving psilocybin or synthetic THC)?
How do you manage antipsychotic-induced prolactinemia?
